ABVC BIOPHARMA, INC. Quarterly Operating Lease, Liability in USD from Q4 2020 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Abvc Biopharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2020 to Q2 2025.
Abvc Biopharma, Inc. Operating Lease, Liability for the quarter ending June 30, 2025 was $459K, a 24.3% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$459K	-$148K	-24.3%	Jun 30, 2025	10-Q	2025-08-13
Q1 2025	$533K	-$175K	-24.7%	Mar 31, 2025	10-Q	2025-04-30
Q4 2024	$640K	-$169K	-20.9%	Dec 31, 2024	10-K	2025-04-15
Q3 2024	$508K	+$294K	+138%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$607K	+$394K	+184%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$708K	+$495K	+232%	Mar 31, 2024	10-Q	2024-05-17
Q4 2023	$809K	+$596K	+279%	Dec 31, 2023	10-K	2024-03-13
Q3 2023	$213K	-$150K	-41.3%	Sep 30, 2023	10-Q	2023-11-15
Q2 2023	$213K	-$137K	-39.1%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$213K	-$136K	-38.8%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$213K	-$134K	-38.5%	Dec 31, 2022	10-Q	2023-11-15
Q3 2022	$364K			Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$350K			Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$349K			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$347K	+$30.9K	+9.78%	Dec 31, 2021	10-Q	2022-11-14
Q4 2020	$316K			Dec 31, 2020	10-K	2022-03-31

Showing 1 to 16 of 16 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.